- Home
- / VG Life Sciences
VG Life Sciences
Stock Price
$0
2024-10-29
Market Capitalization
$2.1 M
2024-10-29
VG Life Sciences Summary
Company Summary
- Overview
- VG Life Sciences (VGLS, also known as SB Technology Holdings, formerly Viral Genetics) is a company that develops therapeutic and diagnostic pharmaceutical and medical products. It focuses on researching drug-resistant cancers and infectious and autoimmune diseases caused by chronic inflammation.
- Type
- Public
- Status
- Active
- Founded
- 1995
- HQ
- New York, NY, US | view all locations
- Website
- http://vglscorp.com
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
New York, NY HQ
United States
447 Broadway 2nd floor #103
VG Life Sciences Financials
Summary Financials
- Net income (Q1, 2015)
- ($1.5M)
- Cash (Q1, 2015)
- $30.1K
- EBIT (Q1, 2015)
- ($801.5K)
- Enterprise value
- $6.5M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026